Objective: This study aims to determine the positive and negative predictive values of self-reported diabetes during the Women's Health Initiative (WHI) clinical trials.
T he United States is experiencing an epidemic of type II diabetes, a major medical problem associated with significant morbidity, mortality, and cost. 1<3 An estimated 24 million adults, or about 8% of the population, are considered to have diabetes (both diagnosed and undiagnosed). 4 The prevalence of diabetes rises sharply with each decade of age in postmenopausal women and surpasses that in men after the seventh decade of life, 5, 6 suggesting that the risk of diabetes not only increases with age but increases more sharply with age for women than for men. In fact, among women participating in two nationally representative surveys (the National Health and Nutrition Examination Survey 1999-2004 and the National Health Interview Survey 2005), about 40% to 45% of participants with diagnosed diabetes were 45 years old or older. 7 Consequently, it is critical to understand the risk factors for and the health consequences of diabetes as women age.
The Women_s Health Initiative (WHI) is a data source that has tremendous untapped potential for exploring the health implications of diabetes for older women. From 1993 to 1998, the WHI enrolled 68,133 postmenopausal women aged 50 to 79 years at baseline in its randomized controlled clinical trials contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. This analysis was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (grant R21 DK074646 to K.L.M., principal investigator). Financial disclosure/conflicts of interest: C.E.L. was the principal investigator of a study at the University of Alabama at Birmingham. The University of Alabama at Birmingham received research funding from Novo Nordisk but did not receive any money directly. All other authors declare no conflicts of interest. and 93,676 women in an observational study. 8, 9 The trials included the dietary modification trial, in which 48,836 eligible women were assigned to either a diet intervention (a low-fat diet high in fruits, vegetables, and grains) or their usual diet. In the hormone trials, placebo was compared with either conjugated equine estrogens alone or conjugated equine estrogens plus medroxyprogesterone acetate in 27,347 women, depending on hysterectomy status. The cohort was followed annually through 2010, with an additional extension study providing 5 years of supplementary observational follow-up through 2015.
The primary outcomes of the trials were breast cancer, colorectal cancer, coronary heart disease, and hip fracture. Selfreports of these outcomes were confirmed via review of medical records by trained physician adjudicators. Incident self-reported diabetes was also assessed as one of the secondary outcomes of the clinical trials but was not independently confirmed by review of medical records. Although fasting blood specimens were collected and stored for all WHI participants, the WHI design called for analysis of only a 6% random sample of the clinical trial participants' samples for fasting glucose and other laboratory measures. Therefore, very few of the trial participants who self-reported diabetes had measurements for fasting blood glucose recorded in the WHI database.
In previous population-based studies, participant selfreports of a diagnosis of diabetes or use of medications for diabetes were confirmed by review of medical records or queries to physicians 64% to 98.5% of the time. 10<24 The wide range of positive predictive values of diabetes self-reports is coupled with a paucity of data on the negative predictive values of not reporting diabetes during longitudinal follow-up studies. 18<20,24 Confirming that participant self-report is a reliable method for classifying diabetes status during the WHI follow-up would greatly enhance the value of the WHI data as a resource for further investigation of the effects of dietary, hormonal, and other influences on diabetes in older women, as well as analyses with diabetes as the exposure of interest.
The purpose of this study was to examine the agreement between self-reports of diabetes in the WHI clinical trials and medical record review, estimating both positive and negative predictive values of self-report. Secondary aims were to compare the confirmation rates of self-reported diabetes between the clinical trials and their intervention and control arms and to assess whether participant characteristics (eg, age, race/ethnicity, education, and body mass index [BMI]) influenced the accuracy of self-reported diabetes.
METHODS

Participants
Participants in this study were recruited from among clinical trial enrollees in four WHI field centers (Minneapolis, MN; Winston-Salem, NC; Birmingham, AL; and Portland, OR). Prevalent self-reported cases were defined as participants who reported a diabetes diagnosis by a physician (medication-treated and untreated) at baseline. Incident cases were defined as all nondiabetic participants at baseline who, during follow-up (including the main WHI trial or its extension), reported being newly prescribed insulin or oral hypoglycemic medication. A random sample of participants without self-reported diabetes (no-diabetes group) was also identified from the roughly 6% of the overall WHI clinical trials cohort who had serial blood samples analyzed for fasting glucose at baseline and on year 1, 3, or 6. Eligible participants were alive and had not been lost to follow-up or had not withdrawn consent to participate in WHI as of the last quarter of 2007.
All eligible women with prevalent or incident self-reported diabetes and the random sample without self-reported diabetes were mailed a request to consent to the study, to sign a release of information to obtain medical records, and to complete a questionnaire seeking verification of their self-report, any symptoms at diagnosis, treatment history, and contact information for healthcare providers. A second questionnaire was sent to women who did not respond to the initial questionnaire. All remaining nonresponders were contacted by telephone. Of the 1,275 women who were invited to participate, 715 were enrolled. Medical records were obtained, and the agreement between WHI self-reports of diabetes and medical record review is reported in this article.
Confirmation of diabetes status by medical record review
Consenting women's outpatient and inpatient medical records related to diabetes diagnosis, treatment, and laboratory testing were requested and reviewed by a trained physician adjudicator (K.L.M., C.E.L., S.B.W., and D.B.) at each site. Medical records of all self-reported incident and prevalent diabetes cases were requested and reviewed. The records of any participant from the no-diabetes group who had only one fasting glucose value available, who had any fasting glucose value of 100 mg/dL or higher, or who reported diabetes on the confirmation questionnaire were also requested and reviewed. If two or more fasting glucose values were lower than 100 mg/dL and the participant reported no diabetes on the confirmation questionnaire, she was assumed, without further review, not to have diabetes.
The medical record review form included notations of diabetes on the problem list or as a diagnosis, the use of medications for diabetes (oral medications and/or insulin), glycosylated hemoglobin levels, fasting and casual plasma glucose values, and results of any oral glucose tolerance tests. Based on the medical records reviewed, the adjudicators recorded their summary impression about whether the participant had diabetes and listed the supporting diagnostic criteria on which their decision was based. Diabetes was defined at the study's inceptionVin accordance with the American Diabetes Association 25 definitionVas one or more of the following (found in the medical records): (1) fasting plasma glucose of 126 mg/dL or higher; (2) symptoms of diabetes (polyuria, polydipsia, and unexplained weight loss) plus casual plasma glucose concentration of 200 mg/dL or higher; (3) 2-hour postload glucose of 200 mg/dL or higher during an oral glucose tolerance test, using a glucose load containing the equivalent of 75 g of anhydrous glucose dissolved in water; and (4) treatment with insulin or an oral hypoglycemic agent.
All physician adjudicators participated in a training session in which 12 sample charts were reviewed and discussed. Furthermore, shortly after medical record abstraction became under way, quality assurance checks were conducted; a second adjudicator (K.L.M.) independently reviewed 12 randomly selected records (incident diabetes, 5; prevalent diabetes, 5; nondiabetes, 2) from each site and verified the summary impression of diabetes versus no diabetes, as supported by the diagnostic elements listed above. Agreement between adjudicators regarding diabetes status was 100%. In addition to the quality assurance sample, the medical records of any discordant cases (the WHI self-report of diabetes did not match the summary impression from the medical record review) were reviewed by a second physician adjudicator (K.L.M.) who made a final determination of diabetes status. The WHI cohort was also linked to Medicare data from 1991 to 2007. Among women aged 65 years or older who have a valid Social Security number, 196 were successfully matched to the Medicare enrollment file.
Statistical analysis Agreement between WHI self-reports of diabetes and medical record review
Self-reports of diabetes confirmed by medical record review were considered true-positives, whereas self-reports of diabetes without medical record confirmation were considered falsepositives. Self-reports of no diabetes confirmed by either two fasting glucose levels lower than 100 mg/dL from WHI laboratory records or information from medical record review were categorized as true-negatives, whereas self-reports of no diabetes with evidence of diabetes in the medical records were categorized as false-negatives. The positive predictive value of self-reported incident diabetes was computed as (true-positives) / (true-positives + false-positives), and the negative predictive value as computed as (true-negatives) / (true-negatives + falsenegatives). Ninety-five percent CIs for the underlying positive and negative predictive values were based on normal distribution approximations to the corresponding exact binomial probability distributions. 26 
Agreement between medical record review and Medicare claims data
We also examined the agreement between diabetes status as assessed by medical record review and diabetes status in Medicare claims data that had been linked to the WHI cohort. This analysis was performed in a subset of women who were continuously enrolled in part A and part B fee-for-service Medicare for at least 2 years before their last date of WHI contact. We used a validated algorithm for identifying diabetes from Medicare claims data that required at least two physician claims for ambulatory care on different days or one inpatient claim (International Classification of Diseases-99 code 250.xx). 27 
Agreement between WHI self-reports of diabetes and medical record review by trial and treatment assignment
We examined whether the random treatment assignment (intervention or control) or the trial in which women were enrolled (estrogen or estrogen + medroxyprogesterone acetate [E + P] diet) was a significant predictor of agreement between self-reported diabetes status and medical record review. A saturated logistic regression model was estimated in which agreement was predicted from self-reported diabetes groups (no diabetes [reference], incident diabetes, or prevalent diabetes), trial (diet [reference], estrogen, or E + P), random treatment assignment (control [reference] or intervention), and all two-way interactions among these variables. For a reduced possibility of overfitting the model to the data, nonsignificant interaction terms were removed individually from the saturated model until all that remained in the reduced logistic model were the three main effects (ie, self-reported diabetes group, trial, and randomly assigned treatment group) and significant interaction terms. Simple effects tests were calculated to help interpret significant interactions.
Agreement between WHI self-reports of diabetes and medical record review by personal characteristics
Finally, we sought to identify the characteristics of study participants other than self-reported diabetes, trial, and treatment assignment, which were associated with the probability of accurately self-reporting diabetes status. This logistic regression model included all of the parameters retained in the previous analysis, as well as characteristics that, when added individually to the model, significantly predicted agreement. The characteristics considered for inclusion were age and BMI (both centered on the mean value), Hispanic ethnicity or nonwhite race (non-Hispanic white [reference]), educational attainment (less than high school, high school, post high school, college degree or higher [reference]), annual household income (GUS$10,000, US$10,000-19,999, US$20,000-34,999, US$35,000-49,999, US$50,000-74,999, QUS$75,000 [reference]), and whether the woman participated in the observational posttrial follow-up component of the WHI (nonparticipant [reference]). Only characteristics that significantly predicted agreement were retained to reduce the likelihood that overfitting the data would produce unstable parameter estimates. Two-way interactions between remaining demographic characteristics and self-reported diabetes status, trial, and treatment assignment were also assessed, and significant interaction terms were retained.
Assessing enrollment bias
Preliminary analyses were conducted to identify any systematic differences between the 715 women in the analytic group and the overall sample of 1,275 women and whether these differences would bias the primary analyses. A propensity model predicted the likelihood of enrollment from features of the women's previous WHI participation (ie, WHI trial, extension study enrollment), personal characteristics (ie, self-reported diabetes, age, race/ethnicity, education, income, BMI), and any significant (P G 0.10) two-way interactions between covariates.
RESULTS
Participants
Of the overall sample of 1,275 women from the four WHI field centers who were invited to participate, 732 (57%) women consented and were enrolled in the study. Among the 543 women who were not enrolled, reasons for nonparticipation included the following: unable to be contacted (41%), refused participation (58%), and inability to participate (eg, dementia; G1%). Medical records were obtained for 715 (98%) of enrolled participants who constituted the analytic sample. Of these, 183 (26%) women self-reported no diabetes in the WHI, 207 (29%) women reported prevalent diabetes, and 325 (45%) women reported incident diabetes. Table 1 provides the demographic characteristics of the overall and analytic samples. One hundred ninety-six (111 women with confirmed prevalent or incident diabetes and 85 women without confirmed diabetes) of the 715 analytic participants met the criteria for inclusion in the Medicare claims data analysis.
Women who had participated in the extension study and who were in the E + P trial and self-reported prevalent diabetes were more likely to enroll. Women who were non-white, lacked high school education, were in both the dietary modification trial and the hormone trial, and had self-reported incident diabetes were less likely to enroll. The propensity model significantly predicted enrollment (W 35 2 = 217.31, P G 0.001), had acceptable discrimination (c = 0.72), and was a good fit to the data (Hosmer-Lemeshow W 8 2 = 3.46, P = 0.90). Next, a logistic regression model was estimated to assess whether the likelihood of enrollment predicted agreement between self-reported diabetes and medical record review among enrollees. A significant prediction would provide evidence that the observed systematic differences between study enrollees and nonenrollees were also related to agreement and therefore biased the study results. However, there was no significant relationship between likelihood of enrollment and agreement (model W 1 2 = 0.008, P = 0.93; c = 0.48; Hosmer-Lemeshow W 8 2 = 11.50, P = 0.18), suggesting that there was no evidence of nonresponse bias, although unmeasured factors related to both enrollment and agreement may nonetheless introduce nonresponse bias. 28 
Agreement between WHI self-reports of diabetes and medical record review
The positive predictive value of self-reporting prevalent diabetes was 91.8% and the positive predictive value of selfreporting incident diabetes was 82.2%, whereas the negative predictive value of self-reporting no diabetes was 94.5% ( Table 2) . Agreement between self-reported diabetes and medical record review was significantly lower in the incident diabetes group than in the prevalent diabetes group and nodiabetes group, which were not different from each other.
Among the 10 false-negatives, medical record review provided ample evidence of diabetes in most (70%) cases. Two cases had limited evidence in the medical records (ie, some inconsistency in progress notes or on the problem list about impaired fasting glucose or prediabetes vs diabetes), but it was enough to meet study criteria for having diabetes. In one case, the participant had medical records indicating lifestylemanaged diabetes, but she accurately answered the WHI survey question that asked only about medication-treated diabetes. About one third of the false-positive cases were attributable to questionnaire scanning errors (eg, scanner picked up an erased response), and roughly one third of them were attributable to unknown reasons. For one quarter of the false-positives, medical records indicated equivocal evidence of diabetes or untreated prediabetes states. Less than 10% of the false-positive cases seemed to be caused by a transient or acute episode of diabetes precipitated by an event such as myocardial infarction or steroid use.
Agreement between medical record review and Medicare claims data
Based on adjudicated determination of whether diabetes was present (n = 111) or was not present (n = 85), the Medicare claims algorithm performed very well in correctly classifying diabetes: 98% (108 of 110) of women who met the claims algorithm criteria had confirmed diabetes by medical record review, and 97% (83 of 86) of women who did not meet the claims algorithm criteria did not have diabetes by medical record review.
Differences in agreement of WHI self-reports of diabetes by WHI trial and treatment assignment
There were some statistically significant differences in agreement between self-reported diabetes and medical record review overall across the WHI trials (P G 0.001). Figure 1 represents the predicted probability of accurately reporting diabetes status by diabetes group and trial. The model that tested these differences had adequate discrimination (c = 0.67) and was a good fit to the data (Hosmer-Lemeshow P = 0.82). Agreement between self-report and medical record review was not different for women in the E + P trial relative to those in the diet trial (P = 0.10), and the difference between E + P and diet was similar across self-reported diabetes groups (interaction, P = 0.33). A different pattern emerged when women in the estrogen and diet trials were compared (interaction, P = 0.04). Although women in the estrogen trial who had prevalent and incident diabetes had somewhat higher agreement than those in the diet trial, these differences were not statistically significant (estrogen prevalent, 96.0%; diet prevalent, 90.5%; P = 0.25; estrogen incident, 87.8%; diet incident, 81.0%; P = 0.19). However, those who reported no diabetes and were in the estrogen trial were less likely to agree than those in the diet trial (estrogen and no diabetes, 88.5%; diet and no diabetes, 98.7%; P = 0.04). There were no significant differences between the treatment arms for any of the trials (P = 0.97).
Differences in agreement by personal characteristics
The final analysis considered personal characteristics in addition to self-reported diabetes group, trial, and treatment group. This model significantly predicted agreement between selfreport and medical record review (W 12 2 = 55.41, P G 0.001) and demonstrated good discrimination (c = 0.75) but was not a good fit to the data (Hosmer-Lemeshow W 8 2 = 15.21, P = 0.06), possibly owing to overfitting. The pattern of effects in Figure 1 did not change when personal characteristics were added. BMI independently predicted agreement between self-report and medical record evidence of diabetes, and it interacted with self-reported diabetes group (P G 0.001). The BMIYdiabetes group interaction (Fig. 2) showed that, although a higher BMI tended to be related to a higher probability of agreement, this relationship was strongest among those with incident diabetes (a 1.7% increase in agreement for every unit increase in BMI), weaker among those with prevalent diabetes, and nonexistent or even slightly negative among those with no evidence of diabetes.
DISCUSSION
In this examination of the agreement between women's self-reported diabetes status during the WHI and medical record evidence of diabetes, we found a high positive predictive value of both prevalent and incident self-reports of diabetes and a high negative predictive value of nonreport of diabetes. When a WHI participant reported that she had diabetes upon enrollment in the WHI, this self-report was confirmed in 92% of cases by medical record review. When a woman reported that she was later diagnosed with diabetes and was started on diabetes treatment, this was confirmed in 82% of cases. Most (two thirds) of the false-positive cases were related to technical errors in questionnaire completion, with diagnostic uncertainty and transient hyperglycemia accounting for the remainder. When a woman in the WHI reported that she did not have diabetes, either upon enrollment or over the course of the trials, this self-report was confirmed in 94.5% of cases. This study is one of the few longitudinal examinations of diabetes self-report, having sought to determine agreement for both prevalent and incident diabetes. There was little variation among the trials and none among the treatment arms. The only personal characteristic that influenced the accuracy of self-report was BMI; women with higher BMI were more likely to correctly report having new-onset diabetes. Finally, for the subset of women who were covered by fee-for-service Medicare, a previously validated claims algorithm had a very high agreement with diabetes status confirmed by medical record review.
Numerous studies have addressed the reliability of selfreport of diabetes. Examinations of the agreement between self-reports with either medical records or physician validation have found concordance values of 64% to 98.5%. 10<22,29 Assessments of agreement between self-report of diabetes and biomedical information (eg, glycosylated hemoglobin, fasting serum glucose) indicate agreements of 95% to 96.3%. 23, 24 The authors of these studies consistently concluded that self-report of diabetes is quite accurate, particularly compared with selfreport of other chronic conditions. Several of these examinations have yielded high concordance values similar to those reported in this article. Skinner et al 21 assessed the agreement between patient report and medical records on five chronic conditions, including diabetes. The patient report was obtained from a self-administered screening questionnaire conducted as part of the Veteran's Health Study. Participants were asked, BHas a doctor ever told you that you have diabetes or high blood sugar?[, as well as about current treatment with medication or diet. Skinner et al reported a 90.8% positive predictive value of diabetes among the study sample of 402 men. Okura et al 19 also reported the agreement between medical record evidence and self-reported diabetes and other chronic disorders. In this examination, randomly selected Mayo Clinic participants aged 45 years or older and residing in Southern Minnesota were asked, BHas a medical provider ever told you that you had any of the following conditions?[ Responses from the 1,950 participants were validated by searching for a diagnosis of diabetes in the comprehensive medical records maintained by Mayo Clinic. Okura et al found a 94.3% positive predictive value of diabetes.
Tisnado et al 22 examined the concordance between the medical records and the self-reports of chronic conditions, including diabetes, in 1,270 women from 39 West Coast area healthcare organizations. Self-report was obtained from a participant survey designed to measure disease based on four components of the care process: diagnoses, clinical services received, counseling and referrals, and medication use. Medical records were reviewed, and data on diabetes in these four dimensions were collected. Tisnado et al found an overall agreement of 92% between participant self-report and the medical records. A substantial body of literature also describes the concordance of diabetes self-report with claims data. 27 ,30<34 Using a well-established methodology of two or more outpatient claims or one hospital claim, 27 we found excellent agreement between adjudicated self-reported diabetes status and Medicare claims data.
The high concordance of values found in these studies may be explained by the thoroughness or precision of the protocols used to obtain medical record evidence of diabetes. The authors of these examinations either reviewed multiple sources in the medical records (including discharge summaries, problem lists, and medication lists) or sought an explicit physician's diagnosis to confirm self-report of diabetes. In fact, Tisnado et al 22 found greater agreement in their examination when medication use was used as the source of information in the medical records compared with clinical services, counseling, referrals, and even diagnoses.
For other examinations, the rigor with which confirmation of diabetes was sought, as well as the sample sizes, helped explain the variations in concordance. In the Iowa Women's Health Study, participants aged 55 to 69 years were asked, BHave you ever been told by a physician that you had diabetes mellitus (sugar diabetes)?[ Self-report was examined by requesting physicians to confirm the diabetes reported by 44 randomly selected participants. Agreement was found among 28 cases (64%). 10 Male and female participants of a casecontrol study of cataract risk factors in Boston were asked if diabetes had ever been diagnosed by a physician and to report medications that they took regularly. 11 Of self-reported cases, 84% (124 of 148) was confirmed, whereas 78% of reports of insulin use (28 of 36) and 75% (56 of 75) of reports of oral hypoglycemic medication use were confirmed. These studies could also be viewed to have imprecise estimates because they were quite small. In contrast, another smaller study (n = 62) from the Nurses' Health Study (NHS) cohort found a higher agreement (98%) between self-report of both incident and prevalent diabetes and medical record review. The NHS represents only female registered nursesVa highly educated and health-conscious study populationVand thus may not be representative of the general population. 29 However, several large, international, population-based validation studies show some range of agreement as well. In a study of Norwegian adults from Nord-TrLndelag County, 163 of 169 (96%) reports of diabetes were verified by review of general practitioner medical records. 12 Furthermore, 95% of self-reports of insulin use and 100% of self-reports of oral hypoglycemic use were confirmed. Another Norwegian survey performed in Finnmark County in the 1970s found a 66% concordance between self-reports and medical records for the diagnosis of diabetes. 13 Huerta et al 24 examined the accuracy of self-reported diabetes, hypertension, and hyperlipidemia using data from the DINO Study, a population-based study of the prevalence of these conditions among the overall adult (Q20 y) residents of Murcia in Southern Spain. Self-reportVelicited by asking BHave you ever been told that you are diabetic or have high blood sugar?[ and by asking about family history of diabetesVwas compared with a fasting serum glucose sample obtained from each participant. Huerta et al found a positive predictive value of 95% for diabetes. In the Longitudinal Aging Study conducted in Amsterdam among men and women aged 55 years or older, 92% of self-reports of diabetes on participant interview were confirmed on a general practitioner questionnaire. 14 Finally, the differences in positive predictive values from these previous studies may also be attributable to the characteristics of the study participants, which may contribute to awareness of diabetes, as proposed above in the case of the NHS. The characteristics found to be associated with a lower accuracy of diabetes self-report include family history of diabetes, 24 lower education, advanced age, 20 and decreased cognitive function. 23 Several examinations have found that agreement between selfreport of diabetes and medical records or biomedical data decreased as the number of comorbid conditions increased. 18, 20, 21 Our findings indicated that, of the participant characteristics examined (eg, age, race, education, income, and BMI), the only additional factor found to influence the accuracy of a woman's self-report was BMI. Self-reported incident diabetes was more likely to be confirmed by medical record review in women with higher BMI. This finding is in contrast with the results of previous examinations of the factors associated with undiagnosed diabetes, which indicate that individuals who did not know they had diabetes had higher BMI. 35<37 This difference with the current study may be related to the greater health consciousness of women enrolled in the WHI; they may have been more aware of the risk of diabetes conferred by overweight than study participants in other settings.
CONCLUSIONS Strengths and limitations
This large validation study of self-reported diabetes compared with medical record review was a very rigorous examination that used American Diabetes Association criteria as the basis for medical record evidence of diabetes. Although this analysis did not include all women enrolled in the WHI, our study sample involved all WHI participants from four geographically diverse field centers. These centers are a good representation of the overall WHI enrollees with regard to racial, ethnic, and socioeconomic diversity. Furthermore, there was no evidence that the relatively low rate of enrollment (57%) produced bias in the analyses presented here. We were also able to obtain medical records on most enrolled participants and therefore included them in our analytic sample. One of the key strengths of this examination is that few previous longitudinal studies comparing the accuracy of selfreport of diabetes with medical record review have reported on false-negative rates (ie, percentage of participants who do not self-report diabetes but who would be found to have diabetes if external sources of confirmation were sought). Our examination, which found a false-negative rate of 5.5%, helps fill this gap.
The findings of this study, however, should be viewed in light of some limitations. As stated previously, we did not seek to validate the self-reports of all WHI participants but only enrollees in the clinical trial of the WHI at fourValbeit geographically and ethnically diverseVsites. Women who enrolled in the WHI generally tended to be well-educated and motivated by health awareness compared with the general public, which may limit the generalizability of our findings to the broader population. Despite this limitation, the WHI participants in our examination were more diverse than some of the unique participant populations involved in previous studies (eg, the NHS). Furthermore, very little variation by race/ ethnicity or education was noted. Because of the small numbers of non-white participants and those with less than high school education, we may have had limited power to examine these variables as predictors of accuracy of self-report.
Implications for practice and/or policy
The WHI clinical trials offer a wealth of data on patient outcomes, including cancer, cardiovascular disease, and hip fracture, which were confirmed via medical record review. The body of literature shows wide variations in the validity of self-reported diabetes in diverse populations; however, in general, diabetes is one of the self-reported outcomes with the highest validity. The results of this study indicate that both WHI information on self-reported diabetes status and Medicare claims are reliable proxies for medical record review and should result in little misclassification.
